14 results
424B3
EVOK
Evoke Pharma Inc
14 Mar 24
Prospectus supplement
6:44pm
purchasing. It is possible that additional governmental action is taken in response to the COVID-19 pandemic. In addition, regional healthcare authorities … caused by the COVID-19 pandemic at the time, we were unable to conduct the trial within the agreed-upon timeline. The timing of initiation
8-K
EVOK
Evoke Pharma Inc
27 Nov 23
Other Events
4:30pm
pandemic may continue to disrupt Evoke’s and EVERSANA’s business operations impairing the ability to commercialize GIMOTI and Evoke’s ability
8-K
EX-99.1
EVOK
Evoke Pharma Inc
15 May 23
Evoke Pharma Reports First Quarter 2023 Financial Results
4:23pm
market demand for GIMOTI; Evoke’s ability to obtain additional financing as needed to support its operations; the COVID-19 pandemic may continue
8-K
banr 86oern7
9 May 23
Other Events
10:00am
8-K
augu4ir9t6v
1 May 23
Other Events
4:04pm
8-K
prmp248k
20 Apr 23
Other Events
4:10pm
8-K
rhrx4
6 Apr 23
Other Events
2:00pm
8-K
55ez3959fwf4pal5h
14 Jan 21
Evoke Pharma Announces Proposed Public Offering of Common Stock
5:22pm
424B5
e6l a4yb00w3j
14 Jan 21
Prospectus supplement for primary offering
5:19pm
424B5
bkhwve 2x6u2bc
13 Jan 21
Prospectus supplement for primary offering
4:34pm
8-K
7haj7m7qo
13 Jan 21
Results of Operations and Financial Condition
4:02pm
- Prev
- 1
- Next